News & insights
Date: March 2011 | Client: Global Fund | Sector: Global health | Epidemics and communicable diseases | Market dynamics, supply & access | Expertise: Health economics & evaluation
Drugs and diagnostics for communicable diseases
The purpose of the study was to support the Global Fund in identifying one-to-two priority product categories and future market-shaping strategic interventions for the shortlisted product categories. The study involved a combination of extensive desk research and review of available literature and data, as well as consultations with key stakeholders across the three disease areas.
To find out more, please contact our experts listed below.
